NewBioRx™ provides ultra-pure research peptides, proteins, and amino acid derivatives for scientific and laboratory use. Based in the United States, the company offers a portfolio of more than 50 compounds, including BPC-157, TB-500, CJC-1295/Ipamorelin, GHK-Cu, MOTS-C, and next-generation GLP-1 agonists such as Retatrutide and Tirzepatide. Every peptide is manufactured using advanced solid-phase and solution-phase synthesis techniques and tested to exceed 99% purity through rigorous HPLC and mass spectrometry analysis at each production stage. In addition, NewBioRx™ offers a Pharmaceutical Grade peptide pen line. All products are designated strictly for research purposes and are not for human consumption.